Global Anti-Obesity Drugs Market Research Report 2020

Global Anti-Obesity Drugs Market Research Report 2020

Table of Contents
1 Anti-Obesity Drugs Market Overview
1.1 Product Overview and Scope of Anti-Obesity Drugs
1.2 Anti-Obesity Drugs Segment by Type
1.2.1 Global Anti-Obesity Drugs Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Prescription Drugs
1.2.3 OTC drugs
1.3 Anti-Obesity Drugs Segment by Application
1.3.1 Anti-Obesity Drugs Sales Comparison by Application: 2020 VS 2026
1.3.2 6-18 Callant
1.3.3 18-30 Adult
1.3.4 30-60Middle-Aged
1.3.5 Others
1.4 Global Anti-Obesity Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti-Obesity Drugs Revenue 2015-2026
1.4.2 Global Anti-Obesity Drugs Sales 2015-2026
1.4.3 Anti-Obesity Drugs Market Size by Region: 2020 Versus 2026
2 Global Anti-Obesity Drugs Market Competition by Manufacturers
2.1 Global Anti-Obesity Drugs Sales Market Share by Manufacturers (2015-2020)
2.2 Global Anti-Obesity Drugs Revenue Share by Manufacturers (2015-2020)
2.3 Global Anti-Obesity Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Anti-Obesity Drugs Manufacturing Sites, Area Served, Product Type
2.5 Anti-Obesity Drugs Market Competitive Situation and Trends
2.5.1 Anti-Obesity Drugs Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Anti-Obesity Drugs Players (Opinion Leaders)
3 Anti-Obesity Drugs Retrospective Market Scenario by Region
3.1 Global Anti-Obesity Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Anti-Obesity Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Anti-Obesity Drugs Market Facts & Figures by Country
3.3.1 North America Anti-Obesity Drugs Sales by Country
3.3.2 North America Anti-Obesity Drugs Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Anti-Obesity Drugs Market Facts & Figures by Country
3.4.1 Europe Anti-Obesity Drugs Sales by Country
3.4.2 Europe Anti-Obesity Drugs Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Anti-Obesity Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Anti-Obesity Drugs Sales by Region
3.5.2 Asia Pacific Anti-Obesity Drugs Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Anti-Obesity Drugs Market Facts & Figures by Country
3.6.1 Latin America Anti-Obesity Drugs Sales by Country
3.6.2 Latin America Anti-Obesity Drugs Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Anti-Obesity Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Anti-Obesity Drugs Sales by Country
3.7.2 Middle East and Africa Anti-Obesity Drugs Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Anti-Obesity Drugs Historic Market Analysis by Type
4.1 Global Anti-Obesity Drugs Sales Market Share by Type (2015-2020)
4.2 Global Anti-Obesity Drugs Revenue Market Share by Type (2015-2020)
4.3 Global Anti-Obesity Drugs Price Market Share by Type (2015-2020)
4.4 Global Anti-Obesity Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Anti-Obesity Drugs Historic Market Analysis by Application
5.1 Global Anti-Obesity Drugs Sales Market Share by Application (2015-2020)
5.2 Global Anti-Obesity Drugs Revenue Market Share by Application (2015-2020)
5.3 Global Anti-Obesity Drugs Price by Application (2015-2020)
6 Company Profiles and Key Figures in Anti-Obesity Drugs Business
6.1 Pfizer
6.1.1 Corporation Information
6.1.2 Pfizer Description, Business Overview and Total Revenue
6.1.3 Pfizer Anti-Obesity Drugs Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Pfizer Products Offered
6.1.5 Pfizer Recent Development
6.2 Merck
6.2.1 Merck Anti-Obesity Drugs Production Sites and Area Served
6.2.2 Merck Description, Business Overview and Total Revenue
6.2.3 Merck Anti-Obesity Drugs Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Merck Products Offered
6.2.5 Merck Recent Development
6.3 F.Hoffmann-La Roche
6.3.1 F.Hoffmann-La Roche Anti-Obesity Drugs Production Sites and Area Served
6.3.2 F.Hoffmann-La Roche Description, Business Overview and Total Revenue
6.3.3 F.Hoffmann-La Roche Anti-Obesity Drugs Sales, Revenue and Gross Margin (2015-2020)
6.3.4 F.Hoffmann-La Roche Products Offered
6.3.5 F.Hoffmann-La Roche Recent Development
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Anti-Obesity Drugs Production Sites and Area Served
6.4.2 GlaxoSmithKline Description, Business Overview and Total Revenue
6.4.3 GlaxoSmithKline Anti-Obesity Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 GlaxoSmithKline Products Offered
6.4.5 GlaxoSmithKline Recent Development
6.5 AstraZeneca
6.5.1 AstraZeneca Anti-Obesity Drugs Production Sites and Area Served
6.5.2 AstraZeneca Description, Business Overview and Total Revenue
6.5.3 AstraZeneca Anti-Obesity Drugs Sales, Revenue and Gross Margin (2015-2020)
6.5.4 AstraZeneca Products Offered
6.5.5 AstraZeneca Recent Development
6.6 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Anti-Obesity Drugs Production Sites and Area Served
6.6.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
6.6.3 Boehringer Ingelheim Anti-Obesity Drugs Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Boehringer Ingelheim Products Offered
6.6.5 Boehringer Ingelheim Recent Development
6.7 Novo Nordisk
6.6.1 Novo Nordisk Anti-Obesity Drugs Production Sites and Area Served
6.6.2 Novo Nordisk Description, Business Overview and Total Revenue
6.6.3 Novo Nordisk Anti-Obesity Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Novo Nordisk Products Offered
6.7.5 Novo Nordisk Recent Development
6.8 Eisai
6.8.1 Eisai Anti-Obesity Drugs Production Sites and Area Served
6.8.2 Eisai Description, Business Overview and Total Revenue
6.8.3 Eisai Anti-Obesity Drugs Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Eisai Products Offered
6.8.5 Eisai Recent Development
6.9 Norgine
6.9.1 Norgine Anti-Obesity Drugs Production Sites and Area Served
6.9.2 Norgine Description, Business Overview and Total Revenue
6.9.3 Norgine Anti-Obesity Drugs Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Norgine Products Offered
6.9.5 Norgine Recent Development
6.10 Arena Pharmaceuticals
6.10.1 Arena Pharmaceuticals Anti-Obesity Drugs Production Sites and Area Served
6.10.2 Arena Pharmaceuticals Description, Business Overview and Total Revenue
6.10.3 Arena Pharmaceuticals Anti-Obesity Drugs Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Arena Pharmaceuticals Products Offered
6.10.5 Arena Pharmaceuticals Recent Development
6.11 Orexigen Therapeutics
6.11.1 Orexigen Therapeutics Anti-Obesity Drugs Production Sites and Area Served
6.11.2 Orexigen Therapeutics Anti-Obesity Drugs Description, Business Overview and Total Revenue
6.11.3 Orexigen Therapeutics Anti-Obesity Drugs Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Orexigen Therapeutics Products Offered
6.11.5 Orexigen Therapeutics Recent Development
6.12 Vivus
6.12.1 Vivus Anti-Obesity Drugs Production Sites and Area Served
6.12.2 Vivus Anti-Obesity Drugs Description, Business Overview and Total Revenue
6.12.3 Vivus Anti-Obesity Drugs Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Vivus Products Offered
6.12.5 Vivus Recent Development
6.13 Alizyme
6.13.1 Alizyme Anti-Obesity Drugs Production Sites and Area Served
6.13.2 Alizyme Anti-Obesity Drugs Description, Business Overview and Total Revenue
6.13.3 Alizyme Anti-Obesity Drugs Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Alizyme Products Offered
6.13.5 Alizyme Recent Development
6.14 Rhythm Pharmaceuticals
6.14.1 Rhythm Pharmaceuticals Anti-Obesity Drugs Production Sites and Area Served
6.14.2 Rhythm Pharmaceuticals Anti-Obesity Drugs Description, Business Overview and Total Revenue
6.14.3 Rhythm Pharmaceuticals Anti-Obesity Drugs Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Rhythm Pharmaceuticals Products Offered
6.14.5 Rhythm Pharmaceuticals Recent Development
6.15 Shionogi
6.15.1 Shionogi Anti-Obesity Drugs Production Sites and Area Served
6.15.2 Shionogi Anti-Obesity Drugs Description, Business Overview and Total Revenue
6.15.3 Shionogi Anti-Obesity Drugs Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Shionogi Products Offered
6.15.5 Shionogi Recent Development
6.16 Zafgan
6.16.1 Zafgan Anti-Obesity Drugs Production Sites and Area Served
6.16.2 Zafgan Anti-Obesity Drugs Description, Business Overview and Total Revenue
6.16.3 Zafgan Anti-Obesity Drugs Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Zafgan Products Offered
6.16.5 Zafgan Recent Development
7 Anti-Obesity Drugs Manufacturing Cost Analysis
7.1 Anti-Obesity Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Anti-Obesity Drugs
7.4 Anti-Obesity Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Anti-Obesity Drugs Distributors List
8.3 Anti-Obesity Drugs Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Anti-Obesity Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Anti-Obesity Drugs by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Anti-Obesity Drugs by Type (2021-2026)
10.2 Anti-Obesity Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Anti-Obesity Drugs by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Anti-Obesity Drugs by Application (2021-2026)
10.3 Anti-Obesity Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Anti-Obesity Drugs by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Anti-Obesity Drugs by Region (2021-2026)
10.4 North America Anti-Obesity Drugs Estimates and Projections (2021-2026)
10.5 Europe Anti-Obesity Drugs Estimates and Projections (2021-2026)
10.6 Asia Pacific Anti-Obesity Drugs Estimates and Projections (2021-2026)
10.7 Latin America Anti-Obesity Drugs Estimates and Projections (2021-2026)
10.8 Middle East and Africa Anti-Obesity Drugs Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Anti-Obesity Drugs Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Anti-Obesity Drugs Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Anti-Obesity Drugs Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Anti-Obesity Drugs Manufacturers Covered in This Study
Table 5. Global Anti-Obesity Drugs Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Anti-Obesity Drugs Sales Share by Manufacturers (2015-2020)
Table 7. Global Anti-Obesity Drugs Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Anti-Obesity Drugs Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Anti-Obesity Drugs Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Anti-Obesity Drugs Sales Sites and Area Served
Table 11. Manufacturers Anti-Obesity Drugs Product Types
Table 12. Global Anti-Obesity Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Anti-Obesity Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Obesity Drugs as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Anti-Obesity Drugs Players
Table 16. Global Anti-Obesity Drugs Sales (K Units) by Region (2015-2020)
Table 17. Global Anti-Obesity Drugs Sales Market Share by Region (2015-2020)
Table 18. Global Anti-Obesity Drugs Revenue (Million US$) by Region (2015-2020)
Table 19. Global Anti-Obesity Drugs Revenue Market Share by Region (2015-2020)
Table 20. North America Anti-Obesity Drugs Sales by Country (2015-2020) (K Units)
Table 21. North America Anti-Obesity Drugs Sales Market Share by Country (2015-2020)
Table 22. North America Anti-Obesity Drugs Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Anti-Obesity Drugs Revenue Market Share by Country (2015-2020)
Table 24. Europe Anti-Obesity Drugs Sales by Country (2015-2020) (K Units)
Table 25. Europe Anti-Obesity Drugs Sales Market Share by Country (2015-2020)
Table 26. Europe Anti-Obesity Drugs Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Anti-Obesity Drugs Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Anti-Obesity Drugs Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Anti-Obesity Drugs Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Anti-Obesity Drugs Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Anti-Obesity Drugs Revenue Market Share by Region (2015-2020)
Table 32. Latin America Anti-Obesity Drugs Sales by Country (2015-2020) (K Units)
Table 33. Latin America Anti-Obesity Drugs Sales Market Share by Country (2015-2020)
Table 34. Latin America Anti-Obesity Drugs Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Anti-Obesity Drugs Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Anti-Obesity Drugs Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Anti-Obesity Drugs Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Anti-Obesity Drugs Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Anti-Obesity Drugs Revenue Market Share by Country (2015-2020)
Table 40. Global Anti-Obesity Drugs Sales (K Units) by Type (2015-2020)
Table 41. Global Anti-Obesity Drugs Sales Share by Type (2015-2020)
Table 42. Global Anti-Obesity Drugs Revenue (Million US$) by Type (2015-2020)
Table 43. Global Anti-Obesity Drugs Revenue Share by Type (2015-2020)
Table 44. Global Anti-Obesity Drugs Price (USD/Unit) by Type (2015-2020)
Table 45. Global Anti-Obesity Drugs Sales (K Units) by Application (2015-2020)
Table 46. Global Anti-Obesity Drugs Sales Market Share by Application (2015-2020)
Table 47. Global Anti-Obesity Drugs Sales Growth Rate by Application (2015-2020)
Table 48. Pfizer Anti-Obesity Drugs Corporation Information
Table 49. Pfizer Description and Business Overview
Table 50. Pfizer Anti-Obesity Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. Pfizer Main Product
Table 52. Pfizer Recent Development
Table 53. Merck Anti-Obesity Drugs Corporation Information
Table 54. Merck Corporation Information
Table 55. Merck Anti-Obesity Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Merck Main Product
Table 57. Merck Recent Development
Table 58. F.Hoffmann-La Roche Anti-Obesity Drugs Corporation Information
Table 59. F.Hoffmann-La Roche Corporation Information
Table 60. F.Hoffmann-La Roche Anti-Obesity Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. F.Hoffmann-La Roche Main Product
Table 62. F.Hoffmann-La Roche Recent Development
Table 63. GlaxoSmithKline Anti-Obesity Drugs Corporation Information
Table 64. GlaxoSmithKline Corporation Information
Table 65. GlaxoSmithKline Anti-Obesity Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. GlaxoSmithKline Main Product
Table 67. GlaxoSmithKline Recent Development
Table 68. AstraZeneca Anti-Obesity Drugs Corporation Information
Table 69. AstraZeneca Corporation Information
Table 70. AstraZeneca Anti-Obesity Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. AstraZeneca Main Product
Table 72. AstraZeneca Recent Development
Table 73. Boehringer Ingelheim Anti-Obesity Drugs Corporation Information
Table 74. Boehringer Ingelheim Corporation Information
Table 75. Boehringer Ingelheim Anti-Obesity Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Boehringer Ingelheim Main Product
Table 77. Boehringer Ingelheim Recent Development
Table 78. Novo Nordisk Anti-Obesity Drugs Corporation Information
Table 79. Novo Nordisk Corporation Information
Table 80. Novo Nordisk Anti-Obesity Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Novo Nordisk Main Product
Table 82. Novo Nordisk Recent Development
Table 83. Eisai Anti-Obesity Drugs Corporation Information
Table 84. Eisai Corporation Information
Table 85. Eisai Anti-Obesity Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Eisai Main Product
Table 87. Eisai Recent Development
Table 88. Norgine Anti-Obesity Drugs Corporation Information
Table 89. Norgine Corporation Information
Table 90. Norgine Anti-Obesity Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Norgine Main Product
Table 92. Norgine Recent Development
Table 93. Arena Pharmaceuticals Anti-Obesity Drugs Corporation Information
Table 94. Arena Pharmaceuticals Corporation Information
Table 95. Arena Pharmaceuticals Anti-Obesity Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Arena Pharmaceuticals Main Product
Table 97. Arena Pharmaceuticals Recent Development
Table 98. Orexigen Therapeutics Anti-Obesity Drugs Corporation Information
Table 99. Orexigen Therapeutics Corporation Information
Table 100. Orexigen Therapeutics Anti-Obesity Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Orexigen Therapeutics Main Product
Table 102. Orexigen Therapeutics Recent Development
Table 103. Vivus Anti-Obesity Drugs Corporation Information
Table 104. Vivus Corporation Information
Table 105. Vivus Anti-Obesity Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Vivus Main Product
Table 107. Vivus Recent Development
Table 108. Alizyme Anti-Obesity Drugs Corporation Information
Table 109. Alizyme Corporation Information
Table 110. Alizyme Anti-Obesity Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Alizyme Main Product
Table 112. Alizyme Recent Development
Table 113. Rhythm Pharmaceuticals Anti-Obesity Drugs Corporation Information
Table 114. Rhythm Pharmaceuticals Corporation Information
Table 115. Rhythm Pharmaceuticals Anti-Obesity Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Rhythm Pharmaceuticals Main Product
Table 117. Rhythm Pharmaceuticals Recent Development
Table 118. Shionogi Anti-Obesity Drugs Corporation Information
Table 119. Shionogi Corporation Information
Table 120. Shionogi Anti-Obesity Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. Shionogi Main Product
Table 122. Shionogi Recent Development
Table 123. Zafgan Anti-Obesity Drugs Corporation Information
Table 124. Zafgan Corporation Information
Table 125. Zafgan Anti-Obesity Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 126. Zafgan Main Product
Table 127. Zafgan Recent Development
Table 128. Sales Base and Market Concentration Rate of Raw Material
Table 129. Key Suppliers of Raw Materials
Table 130. Anti-Obesity Drugs Distributors List
Table 131. Anti-Obesity Drugs Customers List
Table 132. Market Key Trends
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Global Anti-Obesity Drugs Sales (K Units) Forecast by Type (2021-2026)
Table 136. Global Anti-Obesity Drugs Sales Market Share Forecast by Type (2021-2026)
Table 137. Global Anti-Obesity Drugs Revenue (Million US$) Forecast by Type (2021-2026)
Table 138. Global Anti-Obesity Drugs Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 139. Global Anti-Obesity Drugs Sales (K Units) Forecast by Application (2021-2026)
Table 140. Global Anti-Obesity Drugs Revenue (Million US$) Forecast by Application (2021-2026)
Table 141. Global Anti-Obesity Drugs Sales (K Units) Forecast by Region (2021-2026)
Table 142. Global Anti-Obesity Drugs Sales Market Share Forecast by Region (2021-2026)
Table 143. Global Anti-Obesity Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 144. Global Anti-Obesity Drugs Revenue Market Share Forecast by Region (2021-2026)
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Anti-Obesity Drugs
Figure 2. Global Anti-Obesity Drugs Sales Market Share by Type: 2020 VS 2026
Figure 3. Prescription Drugs Product Picture
Figure 4. OTC drugs Product Picture
Figure 5. Global Anti-Obesity Drugs Consumption Market Share by Application: 2020 VS 2026
Figure 6. 6-18 Callant
Figure 7. 18-30 Adult
Figure 8. 30-60Middle-Aged
Figure 9. Others
Figure 10. Global Anti-Obesity Drugs Market Size 2015-2026 (US$ Million)
Figure 11. Global Anti-Obesity Drugs Sales Capacity (K Units) (2015-2026)
Figure 12. Global Anti-Obesity Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Anti-Obesity Drugs Sales Share by Manufacturers in 2020
Figure 14. Global Anti-Obesity Drugs Revenue Share by Manufacturers in 2019
Figure 15. The Global 5 and 10 Largest Players: Market Share by Anti-Obesity Drugs Revenue in 2019
Figure 16. Anti-Obesity Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Anti-Obesity Drugs Sales Market Share by Region (2015-2020)
Figure 18. Global Anti-Obesity Drugs Sales Market Share by Region in 2019
Figure 19. Global Anti-Obesity Drugs Revenue Market Share by Region (2015-2020)
Figure 20. Global Anti-Obesity Drugs Revenue Market Share by Region in 2019
Figure 21. North America Anti-Obesity Drugs Sales Market Share by Country in 2019
Figure 22. North America Anti-Obesity Drugs Revenue Market Share by Country in 2019
Figure 23. U.S. Anti-Obesity Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 24. U.S. Anti-Obesity Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Canada Anti-Obesity Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 26. Canada Anti-Obesity Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Europe Anti-Obesity Drugs Sales Market Share by Country in 2019
Figure 28. Europe Anti-Obesity Drugs Revenue Market Share by Country in 2019
Figure 29. Germany Anti-Obesity Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 30. Germany Anti-Obesity Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. France Anti-Obesity Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 32. France Anti-Obesity Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. U.K. Anti-Obesity Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.K. Anti-Obesity Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Italy Anti-Obesity Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 36. Italy Anti-Obesity Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Russia Anti-Obesity Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 38. Russia Anti-Obesity Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Asia Pacific Anti-Obesity Drugs Sales Market Share by Region in 2019
Figure 40. Asia Pacific Anti-Obesity Drugs Revenue Market Share by Region in 2019
Figure 41. China Anti-Obesity Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 42. China Anti-Obesity Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Japan Anti-Obesity Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 44. Japan Anti-Obesity Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. South Korea Anti-Obesity Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 46. South Korea Anti-Obesity Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. India Anti-Obesity Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. India Anti-Obesity Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Australia Anti-Obesity Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. Australia Anti-Obesity Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Taiwan Anti-Obesity Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. Taiwan Anti-Obesity Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Indonesia Anti-Obesity Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 54. Indonesia Anti-Obesity Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Thailand Anti-Obesity Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 56. Thailand Anti-Obesity Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Malaysia Anti-Obesity Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 58. Malaysia Anti-Obesity Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Philippines Anti-Obesity Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 60. Philippines Anti-Obesity Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Vietnam Anti-Obesity Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 62. Vietnam Anti-Obesity Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Latin America Anti-Obesity Drugs Sales Market Share by Country in 2019
Figure 64. Latin America Anti-Obesity Drugs Revenue Market Share by Country in 2019
Figure 65. Mexico Anti-Obesity Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. Mexico Anti-Obesity Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Brazil Anti-Obesity Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. Brazil Anti-Obesity Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Argentina Anti-Obesity Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Anti-Obesity Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Middle East and Africa Anti-Obesity Drugs Sales Market Share by Country in 2019
Figure 72. Middle East and Africa Anti-Obesity Drugs Revenue Market Share by Country in 2019
Figure 73. Turkey Anti-Obesity Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Turkey Anti-Obesity Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Saudi Arabia Anti-Obesity Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Saudi Arabia Anti-Obesity Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. U.A.E Anti-Obesity Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. U.A.E Anti-Obesity Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Sales Market Share of Anti-Obesity Drugs by Type (2015-2020)
Figure 80. Sales Market Share of Anti-Obesity Drugs by Type in 2019
Figure 81. Revenue Share of Anti-Obesity Drugs by Type (2015-2020)
Figure 82. Revenue Market Share of Anti-Obesity Drugs by Type in 2019
Figure 83. Global Anti-Obesity Drugs Sales Growth by Type (2015-2020) (K Units)
Figure 84. Global Anti-Obesity Drugs Sales Market Share by Application (2015-2020)
Figure 85. Global Anti-Obesity Drugs Sales Market Share by Application in 2019
Figure 86. Global Revenue Share of Anti-Obesity Drugs by Application (2015-2020)
Figure 87. Global Revenue Share of Anti-Obesity Drugs by Application in 2020
Figure 88. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. F.Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Eisai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Norgine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Arena Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Orexigen Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Vivus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Alizyme Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Rhythm Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Shionogi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. Zafgan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 104. Price Trend of Key Raw Materials
Figure 105. Manufacturing Cost Structure of Anti-Obesity Drugs
Figure 106. Manufacturing Process Analysis of Anti-Obesity Drugs
Figure 107. Anti-Obesity Drugs Industrial Chain Analysis
Figure 108. Channels of Distribution
Figure 109. Distributors Profiles
Figure 110. Porter's Five Forces Analysis
Figure 111. North America Anti-Obesity Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 112. North America Anti-Obesity Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Europe Anti-Obesity Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 114. Europe Anti-Obesity Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Latin America Anti-Obesity Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 116. Latin America Anti-Obesity Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 117. Middle East and Africa Anti-Obesity Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 118. Middle East and Africa Anti-Obesity Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 119. Asia Pacific Anti-Obesity Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 120. Asia Pacific Anti-Obesity Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs